References
  1. Lauw MIS, Lucas CG, Ohgami RS, et al: Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features. Diagnostics (Basel) 2020;10(12):1076
  2. Hirano Y, Miyawaki S, Tanaka S, et al: Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review. Cancers (Basel) 2021;13(17):4358
  3. Ahrendsen JT, Ta R, Li J, et al: Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive. Am J Clin Pathol 2022;158(2):300-310
  4. Dunbar MJ, Singhal A, Rassekh SR, et al: Evolution of a Pediatric Primary Cerebral ALK-1- Positive Anaplastic Large Cell Lymphoma on Serial MRI. Pediatr Neurosurg 2015;50(3):145-51
  5. Karikari IO, Thomas KK, Lagoo A, et al: Primary cerebral ALK-1-positive anaplastic large cell lymphoma in a child. Case report and literature review. Pediatr Neurosurg 2007;43(6):516-21
  6. Furuya K, Takanashi S, Ogawa A, et al: High-dose methotrexate monotherapy followed by radiation for CD30-positive, anaplastic lymphoma kinase-1-positive anaplastic large-cell lymphoma in the brain of a child. J Neurosurg Pediatr 2014;14(3):311-5
  7. Lee SW, Jung TY, Baek HJ, et al: Dural-Based Primary Central Nervous System Lymphoma with Bone Invasion. World Neurosurg 2020;139:415-418
  8. Liu Q, Chen X, Li G, et al: Primary central nervous system ALK-positive anaplastic large cell lymphoma with CD56 abnormally expression in a Chinese child: Challenge in diagnostic practice. Int J Immunopathol Pharmacol 2020;34:2058738420941756
  9. Merlin E, Chabrier S, Verkarre V, et al: Primary leptomeningeal ALK+ lymphoma in a 13- year-old child. J Pediatr Hematol Oncol 2008;30(12):963-7
  10. Rupani A, Modi C, Desai S, et al: Primary anaplastic large cell lymphoma of central nervous system–a case report. J Postgrad Med 2005;51(4):326-7
  11. Kuntegowdenahalli LC, Jacob LA, Komaranchath AS, et al: A rare case of primary anaplastic large cell lymphoma of the central nervous system. J Cancer Res Ther 2015;11(4):943-5
  12. Feng S, Chen Q, Chen J, et al: Primary anaplastic large cell lymphoma of the central nervous system in a child: A case report. Medicine (Baltimore) 2020;17;99(29):e21115
  13. Pearson ADJ, Barry E, Mossé YP, et al: Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration. Eur J Cancer 2021;157:198-213
  14. Mossé YP, Voss SD, Lim MS, et al: Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study. J Clin Oncol 2017;35(28):3215-3221
  15. Fukano R, Mori T, Sekimizu M, et al: Alectinib for relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: An open-label phase II trial. Cancer Sci 2020;111(12):4540-4547